Cormorant Asset Management »

Galecto shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $40M 1.5M 25.90

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Eyepoint Com New (EYPT)
Edgewise Therapeutics (EWTX)
Erasca (ERAS)
Rapport Therapeutics (RAPP)
Alumis (ALMS)
Abivax Sa Sponsored Ads (ABVX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Dianthus Therapeutics (DNTH)
Bright Minds Biosciences Com New (DRUG)
Olema Pharmaceuticals (OLMA)
Bridgebio Pharma (BBIO)
Bioage Labs (BIOA)
Centessa Pharmaceuticals Sponsored Ads

View all positions for Cormorant Asset Management

Top funds holding Galecto

FMR
Fairmount Funds Management
venBio Select Advisor
VR Adviser
Fcpm Iii Services B.v.
RA Capital Management
Henderson Group
Viking Global Investors
Bellevue Group
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors

View all funds holding Galecto